70260-05-8 Usage
Uses
Used in Organic Synthesis:
3-Bromo-4-(hydroxymethyl)thiophene is used as a key intermediate in the synthesis of various organic compounds. Its unique structure allows for further functionalization and modification, making it a valuable component in the preparation of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-Bromo-4-(hydroxymethyl)thiophene is utilized as a building block for the development of new drugs. Its reactivity and structural features enable the synthesis of biologically active compounds with potential therapeutic applications.
Used in Agrochemicals:
3-Bromo-4-(hydroxymethyl)thiophene is employed as a starting material in the synthesis of agrochemicals, such as pesticides and herbicides. Its properties contribute to the development of effective and environmentally friendly agricultural products.
Used in Material Science:
3-Bromo-4-(hydroxymethyl)thiophene is used as a component in the development of new materials with specific electronic and optoelectronic properties. Its unique molecular structure allows for the creation of materials with tailored characteristics for various applications in the field of material science.
Check Digit Verification of cas no
The CAS Registry Mumber 70260-05-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,2,6 and 0 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 70260-05:
(7*7)+(6*0)+(5*2)+(4*6)+(3*0)+(2*0)+(1*5)=88
88 % 10 = 8
So 70260-05-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H5BrOS/c6-5-3-8-2-4(5)1-7/h2-3,7H,1H2
70260-05-8Relevant academic research and scientific papers
PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE
-
Paragraph 0471-0472, (2014/07/22)
The present invention relates to a compound having the general formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.
HIV protease inhibitors
-
, (2008/06/13)
The present invention relates to novel dihydropyrones with tethered heterocycles having improved pharmacologic properties which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The dihydropyrones are useful in the development of therapies for the treatment of viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of the dihydropyrones and intermediates useful in the preparation of the final compounds.
Phosphorylamides, their preparation and use
-
, (2008/06/13)
A phosphorylamide derivative represented by the general formula (I): STR1 wherein R represents an amino group that may be substituted, or a salt thereof, possesses potent antibacterial activity against Helicobacter bacterium, especially Helicobacter pylori, and is useful for prevention or treatment of digestive diseases caused by Helicobacter bacterium, solely or in combination with an antacid or an acid secretion inhibitor.
